Search results
China Approves AstraZeneca's Tagrisso-Chemotherapy Combo Regime For Previously Untreated Lung Cancer Patients
On Wednesday, China approved AstraZeneca plc's (NYSE:AZN) Tagrisso (osimertinib) with the addition of pemetrexed and platinum-based chemotherapy for the ...
Benzinga via Yahoo
6 days ago
China approves AstraZeneca's Tagrisso-chemo combo as first-line treatment
AstraZeneca said the approval by China's National Medical Products Administration (NMPA) was based on trials which showed that patients given the combination ...
Reuters via Yahoo
6 days ago